Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

Authors

Tom Arends

Published

January 21, 2016

Abstract

Supporters

Support the authors with ResearchCoin

Journal

European Urology

Topics

Intention-To-Treat Analysis

DOI

10.1016/j.eururo.2016.01.006

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

Authors

Tom Arends

Published

January 21, 2016

Abstract

Supporters

Support the authors with ResearchCoin

Journal

European Urology

Topics

Intention-To-Treat Analysis

DOI

10.1016/j.eururo.2016.01.006

Paper

Paper

Paper

Paper

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

Abstract

Supporters

Journal

Topics

DOI

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

Abstract

Supporters

Journal

Topics

DOI